Drug class
Indandione oral anticoagulant; vitamin K antagonist
Mechanism of action
Interferes with hepatic synthesis of functional vitamin K-dependent coagulation factors II, VII, IX and X, reducing the blood’s capacity to form thrombin and fibrin clots.
General use cases
- Prevention and treatment of venous thrombosis and pulmonary embolism.
- Prevention of systemic embolisation in selected patients with atrial fibrillation and rheumatic heart disease, and after insertion of prosthetic heart valves, under the product label and INR monitoring.
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
